Call for Abstract

9th Asia Pacific STD and Infectious Diseases Congress, will be organized around the theme “Advancements, Novel approaches for prevention & control of STD and Infectious Diseases”

STD Asia Pacific Congress 2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in STD Asia Pacific Congress 2019

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

The term ‘Sexually Transmitted Diseases’ (curtailed STDs) alludes to a cluster of sicknesses that can be transmitted beginning with one individual then onto the following through the sharing of body liquids including discharge, vaginal liquids, blood, and distinctive fluids. They have a wide range of causes (counting microscopic organisms & Infections), they deliver an assortment of manifestations (or nonattendance of side effects), and they have altogether different impacts on the body when left untreated which is specified as STD symptoms. There are various types of STDs from benign to malignant and harmful ones. Nearly twenty various infections are known to be transmitted through sexual contacts. Most Sexually Transmitted Diseases affect both men and women, but in most of the cases the health problems they cause can be more severe for women. If a pregnant woman has an STD, it can cause consequential health problems for the baby.
Sexually transmitted ailments are transmitted when body fluids from a polluted individual come into indicate contact with another person. As their name infers, the most well-known course through which this body fluid sharing happens is sexual activity.
Chlamydia | Gonorrhoeae | Genital Herpes | HIV-AIDS | Human Papilloma Virus (HPV) | Syphilis | Bacterial Vaginosis | Trichomoniasis | Viral Hepatitis | Zika virus | Ectoparasitics and Arthropods | STD Symptoms | STD Testing | STD Diagnostic kit
  • Track 1-1STIs and HIV/ AIDs
  • Track 1-2Common infectious diseases
  • Track 1-3Pediatric infectious diseases
  • Track 1-4Re-emerging infectious diseases
  • Track 1-5Rare infectious diseases
  • Track 1-6Infectious diseases during pregnancy
  • Track 1-7Tropical infectious diseases
  • Track 1-8Inflammatory infectious diseases
  • Track 1-9Air, food, water and blood borne infectious diseases
  • Track 1-10Neuro infectious diseases
  • Track 1-11Geriatric infectious diseases
Exposure of susceptible to infected individuals can be influenced through counselling of patients to reduce early sexual debut and concurrent sexual partners, and to promote the performance of safer sexual activities, including:
·         Non-penetrative sexual acts
·         Consistent and correct use of condom
·         STI & HIV Testing followed by commitment to monogamy.
The efficiency of transmission during exposure between the susceptible and infectious partners can be influenced by number of primary care physician interventions. Counselling and advising patients to use “safer sex” practices such as condom and avoidance of the unprotected vaginal or anal intercourse which can be substantially reduce the transmission of STI pathogens. The applications of epidemiologic treatment to patients who had a known exposure to a STI can reduce transmission presumably by treating patients either before symptoms develop or during the incubation period of the infection. Other forms of post-exposure prophylaxis have been used to prevent HIV infection following needle - stick, or sexual assault exposure. Finally the physicians can reduce the infectivity of some of the infected individuals by the use of suppressive antimicrobial therapy.
HIV Stigma and Discrimination | Inequality | Racial/ethnic Discrimination | Unemployment | Sex ratio | Volume of migration | Health care coverage | Poverty
  • Track 2-1Chronic Lifestyle Changes
  • Track 2-2Immunodeficiency
  • Track 2-3STI Viral Pathogens
  • Track 2-4Incubation period of the infection
  • Track 2-5Post-exposure prophylaxis
  • Track 2-6Suppressive antimicrobial therapy
  • Track 2-7Efficiency Of Transmission
  • Track 2-8Haematological Diagnosis
The syndromic approach is an important tool in the control of STIs and their sequelae, management by syndrome alone is inadequate because infections with important pathogens such as Chlamydia trachomatis and Neisseria gonorrhoeae  can be present without any symptoms . It is important to recognize syndromes to findings  that may be caused by one or more sexually transmitted pathogens and in managing STIs, diagnosis by syndrome and laboratory diagnosis by testing for a specific organism which are both important and complementary. Diagnosis of a syndrome or findings according to standard criteria predicts the likelihood that any specific pathogen is present and thus facilitates initiation of appropriate empiric treatment at the initial visit than deferring treatment until there is microbiological confirmation. WHO have developed simple flowcharts (called algorithms) to guide health care providers using the syndromic approach to manage seven syndromes.
Enteric Infections | Epididymitis | Genital ulcers | Ophthalmia neonatorum | Urethritis | Vulvovaginitis, vaginosis | Acute proctitis | Wet mount examination, culture or NAA test
  • Track 3-1Sexually transmitted infection(STI)-related enteric infections
  • Track 3-2Cervicitis(Inflammation of Cervix)
  • Track 3-3Urethritis(Inflammation of Urethra)
  • Track 3-4Pelvic Inflammatory Disease
  • Track 3-5Hepatitis(Inflammation of Liver)
  • Track 3-6Prostatitis(Inflammation of Prostate)
STI epidemiology and management has evolved interactively, particularly in the developing nations. Technological frontiers in the diagnosis, screening, and treatment evaluation and widespread implementation of new case-management algorithms; and changes in risk behaviors in response to the AIDS epidemic have all influenced the dynamic typology of STIs. For Every year worldwide, there are approximately 357 million of new infections of syphilis, chlamydia, gonorrhoea, and trichomoniasis. The major recent advances in the STI prevention is the early success of a prophylactic, monovalent human papillomavirus (HPV) type 16 vaccine, HPV vaccines may be able to prevent genital and anal cancers in foreseeable future.
Frequency of infection | antimicrobial resistance patterns | clinical presentation | Assessing risk | treatment regimens | Casual sexual relationships | long-term complications | Human Papilloma Virus (HPV)
  • Track 4-1Syndromic Management
  • Track 4-2Role of Core Groups
  • Track 4-3Antibiotic Use
  • Track 4-4Drug Resistance
  • Track 4-5Sexual Health Care
  • Track 4-6Social Risk Markers
  • Track 4-7Behavioral Risk Factors
  • Track 4-8Clinical interventions
Infectious diseases prevention & control will helpful to prevent the transmission of infectious diseases. STI control efforts have been increased in relation to the HIV programme priorities that are funded, implemented and evaluated independently for other STI control efforts. STI control is the public health outcome, measured as reduced incidence and prevalence, achieved by implementing strategies composed of the multiple synergistic interventions.
Abnormal development of fetus resulting in the  death, malformation, growth retardation, and functional disorders is defined as the birth defects. Nearly 150,000 babies are born annually with birth defects. Birth defects, including low birth weight babies, are the most leading cause of infant mortality. Chlamydia is the most common sexually transmitted diseases, affects an estimated 100,000 pregnant women every year, according to the Centers for Disease Control and Prevention. In fact, it is  one of the serious causes of infections affecting newborns' eyes and respiratory system.
Exposure to the bacteria during childbirth could lead to infection of the respiratory tract, causing infant pneumonia. While some types of birth defects have declined , mostly by preventive methods, many have increased. According to the CDC study of 38 types of birth defects occurring over the period 1979-89, 27 had increased, including several cardiac defects, chromosomal defects like  trisomy 18, and fetal alcohol syndrome; 9 had remained the same , and only 2 had decreased. Prompt evaluation of the sexual partners is mandatory to prevent reinfection and disrupt transmission of many STDs. Preexposure vaccination is among the most effective methods for preventing some STDs.
Accurate risk assessment | Education | Counselling | Early identification of asymptomatic infection | Effective treatment | Abstinence | Pre-travel advice | Pre-exposure vaccination
  • Track 5-1Treatment for infections
  • Track 5-2Ebola and Zika viral infections diagnosis and cure
  • Track 5-3Tuberculosis, Hepatitis and Malaria treatment and cure
  • Track 5-4Abstinence
  • Track 5-5Good hygienic practices
  • Track 5-6Targeting high-risk populations
  • Track 5-7"The Lowdown" Infographic
  • Track 5-8Alternative therapies
The rate of Developing Infectious Diseases is quickly expanding or debilitates to increment sooner rather than later. The ascent of new irresistible sicknesses or the re-development of the old irresistible ailments is supported by numerous components like advancement of the pathogens, human behavior and practice.
The developing sicknesses can be built up by its presentation into a populace and its capacity to spread starting with one individual then onto the next. Numerous rising and re-rising irresistible infections have been found like Hemorrhagic fever, Encephalitis, Zika virus & West nile virus etc
Neonatal or Infant infections | Early Infant diagnosis | Replacement feeding | WHO guidelines for PMTCT | Vertical transmission | Anti Retroviral Treatment (ART) | HIV-exposed infant | HIV Stigma, Discrimination and PMTCT | Scheduled cesarean delivery (C-section) | Teratogenicity


  • Track 6-1Genetic disorder
  • Track 6-2Poor growth
  • Track 6-3Premature birth
  • Track 6-4Pelvic Inflammatory Disease
  • Track 6-5Mental retardation
  • Track 6-6Low birth weighs
HIV is the virus spread through certain body fluids which attacks the body’s immune system, specifically the CD4 cells, often called as T cells. AIDS is the severe phase of HIV infection. People with AIDS have badly damaged immune systems , they get an increasing number of severe illnesses, called opportunistic infections.
The three phases of HIV infection are:
(1) Acute HIV infection,
(2) Clinical latency, and
(3) AIDS (Acquired Immunodeficiency Syndrome)
HIV is the main cause of the spectrum of disease known as HIV/AIDS. HIV is a retrovirus which primarily infects components of the human immune system such as CD4+ T cells, macrophages and dendritic cells. It directly and indirectly destroys the CD4+ T cells
Human immune deficiency virus infection & Acquired immune deficiency syndrome (HIV/AIDS) is the spectrum of conditions caused due to infection with the human immunodeficiency virus (HIV). HIV is spread primarily by unprotected sex (including the anal and oral sex) contaminated blood transfusions, hypodermic needles, from Mother to child Transmission during the pregnancy, delivery, or breastfeeding.
Diseases in the baby can often be prevented by giving both the mother and child anti-retroviral medication. HIV/AIDS research includes the medical research which attempts to prevent, treat and cure HIV/AIDS along with fundamental research about the nature of HIV as an infectious agent & AIDS as the disease caused by HIV. Governments aided organization and research institutions participate in the HIV/AIDS research which includes behavioral health interventions such as sex education, and drug development, such as research into microbicides for STD, HIV vaccines, and antiretroviral drugs. Medical research areas which include the topics of pre-exposure prophylaxis, post-exposure prophylaxis, circumcision and HIV. Public health officials, Researchers and programs can gain more comprehensive picture of the barriers they face, and the efficacy of present approaches for HIV treatment and prevention, by tracking the standard HIV indicators. Use of the common indicators is an increasing focus of development organizations and researchers.
PrEP (pre-exposure prophylaxis) | Acute Retroviral Syndrome | Acute HIV Infection |  STD clinics |  Opt-out HIV screening |  Antibody Immunoassay | Ag/Ab combination tests | antenatal and postpartum treatment | Adolescents and Young Adults Fact Sheet
  • Track 7-1HIV & Retro Virus
  • Track 7-2Symptoms and diagnosis
  • Track 7-3Risks and Resiliencies
  • Track 7-4Human papillomavirus (HPV) infection
  • Track 7-5PID (Pelvic Inflammatory Disease)
  • Track 7-6UTI’s (Urinary Tract Infections)
  • Track 7-7Herpes and HIV acquisition
  • Track 7-8HIV Molecular and Serology
  • Track 7-9Anti-Retroviral therapy & drugs
  • Track 7-10Genital microbiome and HIV transmission
  • Track 7-11Treatments, prevention and management
Syphilis is sexually transmitted diseases (STD) which have very serious complications when it was left untreated, but it is simple to cure with the correct treatment. Symptoms in adults are divided into phases. The phases can be divided into primary, secondary, latent, and late syphilis. Syphilis can be spread by direct contact with syphilis sore during the vaginal, anal or oral sex. Sores can be found on the penis, vagina, anus, in the rectum, on the lips and in the mouth. Syphilis alos called ‘the great imitator’ as it has so many possible symptoms, many of which look like symptoms from other diseases.
The painless syphilis sore that get after first infected can be confused for an ingrown hair, zipper cut, or other seemingly harmless bump. The syphilis infected baby may be born without signs or symptoms of disease. If not it is not treated immediately, the baby may develop serious problems within a few weeks. Untreated babies can have serious health problems such as cataracts, deafness, or seizures and even can die.
Associated symptoms | Behavioural data | Syphilis outbreaks | Congenital Syphilis |  Highly Active Anti Retroviral Therapy (HAART) | HIV+/MSM Co-Infections |  Private providers  |  STD clinics  |  Health and Mental Hygiene | National STD Curriculum
  • Track 8-1Primary syphilis
  • Track 8-2Secondary syphilis
  • Track 8-3Latent syphilis
  • Track 8-4Tertiary syphilis
  • Track 8-5Congenital syphilis
  • Track 8-6Neurosyphilis
  • Track 8-7Miscarriage/Stillbirth
  • Track 8-8Blindness/Stroke
Depending on the type and form of disease, STDs can be spread with any type of sexual activity. STDs are mostly caused by viruses and bacteria, both bacterial and viral STDs which vary in the treatment and diagnosis. Bacterial STDs, mainly gonorrhea, syphilis, and chlamydia, are often cured with antibiotics. Viral STDs, commonly HIV, HPV (genital warts), Herpes and hepatitis (it is the only STD that can be prevented with a vaccines), have no cure, but their symptoms can be diminish with treatment.
STDs, such as gonorrhea and syphilis, are classified into the "reportable" because when diagnosed they must be reported to the proper health or government agency to prevent their spread and transmission. Gonorrhea, one of the most widespread of the STDs, is caused by the bacterium Neisseria gonorrhoeae, some strains of which are resistant to treatment by penicillin, other drugs of choice. 80 % women and 40 % men diagnosed with chlamydia may not experience any symptoms.
Hepatitis | Chancroid | Gonorrhea | Chancroid | Viral Hepatitis | Trichomoniasis | Vaginitis | Vaginosis | Urethritis | Viral Hepatitis | Giardiasis | Cytomegalovirus | Herpes
  • Track 9-1Lymphogranuloma Venereum (LGV)
  • Track 9-2Cytomegalovirus (CMV)
  • Track 9-3Herpes (HSV1 & HSV2)
  • Track 9-4Genital Warts
  • Track 9-5Cytomegalovirus
  • Track 9-6Viral Hepatitis
  • Track 9-7Vaginitis
  • Track 9-8Pelvic Inflammatory Disease (PID)
  • Track 9-9Nongonococcal Urethritis (NGU)
  • Track 9-10Yeast Infection
Developing Infectious Diseases are those whose rate or the geographic range is fast expanding or debilitates to increment sooner rather than later. The ascent of new irresistible sicknesses or the re-development of the old irresistible ailments is supported by numerous components like advancement of the pathogens, human behavior and practice.
The developing sicknesses can be built up by its presentation into a populace and its capacity to spread starting with one individual then onto the next. Numerous rising and re-rising irresistible infections have been found like Hemorrhagic fever, Encephalitis, Zika virus & West nile virus etc.
Antimicrobial resistance | Mortality | Morbidity | Public health | Communicable diseases | Causative Agents | Contributing Factor| Global Scenario | Strategies to Combat | Autoimmune Disease | Cholera Outbreak | International Health Regulations | Urbanization | Microbial Genetic Mutation | Human Demographics | Lack of Public Health Services.
  • Track 10-1Yellow fever
  • Track 10-2Anthrax
  • Track 10-3Hemorrhagic fever
  • Track 10-4Encephalitis
  • Track 10-5Malaria and Chickungunya
  • Track 10-6Cardiovascular Diseases
  • Track 10-7Renal and Urologic Abnormalities
  • Track 10-8Measles
  • Track 10-9HIV & Polio virus
Having an STD/STI increases the person's risk for various types of cancer. Certain high-risk types of Human Papilloma Virus (HPV) can cause the cervical cancer in women and other cancers includes the cancer of the vulva, vagina. In men, HPV infection can lead to development of penile cancers. HPV also can cause cancers of mouth, throat, and anus in both sexes. It can also cause the oropharyngeal cancer. Acquiring viral hepatitis B or C puts the person at risk for liver cancer, and untreated HIV/AIDS increases the risk for several types of rare cancers, including lymphomas, sarcomas, and cervical cancer. There are the HPV tests that are used to screen for the cervical cancer. These tests are recommended for screening in the women aged 30 years and older. They are not recommended to screen the men, adolescents, or women under the age of 30 years.
High-risk HPV | Food and Drug Administration (FDA) | Benign and Precancerous changes | Cryosurgery | Immune System | Oncology | Monogamy | Vaccination | Carcinogenesis
  • Track 11-1Invasive fungal infection and cancer
  • Track 11-2Head and Neck cancer
  • Track 11-3Sarcomas
  • Track 11-4Oropharyngeal cancer
  • Track 11-5Vulva, Vagina cancers
  • Track 11-6Lymphomas
  • Track 11-7Liver cancer (hepatitis B or C)
  • Track 11-8Mouth and Throat cancers
  • Track 11-9Bacterially driven carcinogenesis
  • Track 11-10HVP mode of cancer development
  • Track 11-11Penile cancers
  • Track 11-12Cervical cancer
  • Track 11-13Gastric Cancer
  • Track 11-14Prostate Cancer
Most of the healthy people’s immune systems kill or contain TB infection without developing symptoms. Latent TB infection is the asymptomatic and non-transmissible form of TB. Hepatitis is the inflammation of liver. There are 5 main types of hepatitis viruses, referred to as types A, B, C, D and E. Twin studies of tuberculosis (TB)  and the chronic HBV infection identified as the strong host genetic component to individual variability in case of disease susceptibility.
Short-course chemotherapy containing the combination of Rifampicin plus Isoniazid has proved to be the highly effective in treatment of tuberculosis, but one of its adverse effects is hepatotoxicity. An estimated 49 million lives are saved through TB diagnosis and treatment between 2000 and 2015. Injection drug abusers, dialysis patients, sex workers, healthcare workers, patients with HIV infection, homeless people, persons in mental hospitals or prisons, and foreign-born persons of countries with highly prevalent HBV / hepatitis C and / or TB are at risk of exposure to both HBV and TB. HBV serology status can be predicted exactly on the basis of a Questionnaire algorithm, including a history of blood transfusion, IV drug abuse, younger age at sexual debut, and multiple sexual partners
Immunodeficiency | Anti-tuberculosis therapy (ATT) | Drug-induced-hepatotoxicity (DIH) | Alcoholism | Malnutrition | Seroreversion illnesses | Patients protocols | Interferon therapy
  • Track 12-1Tuberculosis and STD
  • Track 12-2Auto immune hepatitis
  • Track 12-3Hepatic cirrhosis
  • Track 12-4Hepatitis C Coalition
  • Track 12-5Acute hepatitis
  • Track 12-6Tuberculosis in children
  • Track 12-7Pulmonary/Extrapulmonary TB
  • Track 12-8Pulmonary/Extrapulmonary TB
  • Track 12-9Hepatotoxicity
  • Track 12-10Tuberculosis - Health impact
  • Track 12-11Prevalence
  • Track 12-12TB and HIV co-infection
  • Track 12-13Liver disorders
Reproductive Infectious Disease is a subspecialty of Obstetrics & Gynecology that deals mainly with infections of women. These may be infections of the reproductive tract, infections during pregnancy, or any other infections that affect the life and well-being of women. Health care practitioners strives to provide the latest evidence-based treatments to women suffering from infectious diseases or related complications. In addition to providing care to women with HIV in pregnancy and beyond, the treatment for complicated or unusual post-operative infections, pelvic infections, and sexually transmitted infections.
Children are often at an increased risk for certain conditions while their immune systems are still developing. Because diagnosis and care for an infectious disease can be complex, it is important for the diagnose accurately and treat the child's condition. Children's comprehensive services providers include care for children with infectious diseases and epidemiological tracking that, for contagious conditions, helps limit the spread of infection and prevent further outbreaks like Bone and joint infections, Fever of unknown origins, HIV/AIDS, Infectious mononucleosis, Influenza, Lyme disease Meningitis, MRSA (methicillin-resistant staphylococcus aureus), Respiratory syncytial virus (RSV) Staph infections, Tuberculosis.
Best Care For Children
Children are not just small adults, their bodies are growing and have unique medical needs. They usually express their concerns differently than adults do. They cannot always answer medical questions, and are not always able to be patient and cooperative.  Pediatric infectious diseases specialists know how to examine and treat children in a way that makes them relaxed and cooperative. They understand the unique signs, symptoms, treatments, outcomes/prognoses associated with infectious diseases in children, which can be quite different from those of adults with such infections.
  • Track 13-1Acute and chronic infections
  • Track 13-2Pediatric infection control
  • Track 13-3Pediatric and adolescent HIV disease
  • Track 13-4Congenital and perinatal infections
  • Track 13-5Antibiotic stewardship in pediatrics
  • Track 13-6Blood infections
  • Track 13-7Pediatric Tuberculosis
  • Track 13-8Pediatric parasitic diseases
  • Track 13-9Pediatric tropical diseases
  • Track 13-10Modes and mechanisms of transmission
The immune system is the host defence system composed of many biological structures and processes within an organism which protects against disease
The invulnerable reaction to a disease depends if the contamination is out of the blue or the contamination has happened previously. At the point once when the pathogens has just assaulted and has produced the memory cells in the host the reaction to the contamination will be exceptional on the following presentation. The invulnerable reaction to the remote body in the host is because of arrangement of other reaction from the resistant cells.
Despite whether compelling ailment administrator is the"old partner" or another, creating hazardous, the sheltered system's battle against it is normally the principal line of immune resistance. The safe response is the best way to destroy the irresistible illness when the drug is inaccessible.
Immuno-Deficiencies | Autoimmunity | Hypersensitivity | Tumor Immunology | Immuno stimulation |       Genetic Jugglery for resistance.          
  • Track 14-1Intrinsic Resistance for survival
  • Track 14-2Resistome for the resistance
  • Track 14-3Modes and mechanisms of transmission
Sexually transmitted diseases (STDs) remain the major Global public health challenge. Biological factors in women place at greater risk than men for the severe health consequences of STDs. The two major commonly reported infectious diseases in America is chlamydia and Gonorrhea which imposes a particular risk to the women’s health, as both can result in infertility if left untreated. Global Trends of STD are more toward viral origin as compare to bacterial origin. Epidemiology of infectious diseases helped to develop methodology used in clinical research, public health studies and to a lesser extent basic research in the biological sciences.
Ebola Frontline | Medical innovations | Community Engagement | Global Immunisation | World Health Organization (WHO) | Universal Healthcare Coverage (UHC) | Sustainable Development Goals (SDG) | Small pox and Cholera Outbreaks | Biosurveillance
  • Track 15-1STD-AIDS Testing Market by testing devices
  • Track 15-2Experimental Treatments for Ebola Viral Disease
  • Track 15-3Molecular genetics of Ebola Virus
  • Track 15-4Ebola Outbreak and Prevention
  • Track 15-5Market Dynamics
  • Track 15-6Technological Advancements for STDs diagnostic market
  • Track 15-7Private & public laboratory testing
  • Track 15-8STD-AIDS Testing Market by geography
  • Track 15-9STD-AIDS Testing Market by location
  • Track 15-10Molecular mechanisms of Ebola Virus Pathogenesis
Women who are pregnant can become infected (host vector) with the same STDs as women who are not pregnant. STDs and infectious diseases can complicate the pregnancy and may have serious effects on both mother and the developing baby. STDs/STIs during pregnancy can also cause Miscarriage, Ectopic pregnancy, Preterm labor and delivery, Birth defects and New born death etc. Some of the problems may be seen at birth; others may not be discovered until months or years later. Testing, diagnosis and treating the pregnant women for STDs and infections is the important way to prevent serious health complications to both mother and baby that may otherwise happen with infection. STDs, such as chlamydia, gonorrhea, syphilis, trichomoniasis and BV can all be treated with antibiotics that are safe to take during pregnancy.
Perinatal HIV transmission | Cesarean delivery | Teratogenicity | pre-exposure prophylaxis (PrEP) | Perinatal Acquired HIV | Integrated Human Immunodeficiency Virus Surveillance and Prevention Programs for Health
  • Track 16-1Types of STDs in pregnancy
  • Track 16-2Embryo/fetus affect
  • Track 16-3Risk of transmission
  • Track 16-4Antibiotics Treatment
  • Track 16-5Antiviral medications
  • Track 16-6Antimicrobial drugs
Some STDs and infections, such as such as gonorrhea, Chlamydia, and syphilis, are caused by bacteria. They are usually effectively treated with antibiotics. Most of the STDs can be effectively prevented and treated through pre-exposure vaccination with widely available vaccines, including HAV, HBV, and HPV. Viral STDs are mostly highly persistent despite current therapeutic options or have no acceptable treatment available. Therefore, vaccines for certain viral STDs are in use, and others are in developmental process.
Vaccine-preventable diseases| Immune response | Clinical Trials | HIV Vaccine Development | Treatment-Free HIV Remission | Investigational drugs | Informed consent.
  • Track 17-1HPV Vaccines
  • Track 17-2Gonorrhea and Chlamydia vaccines
  • Track 17-3Tetanus vaccine
  • Track 17-4Polio vaccine
  • Track 17-5Mumps vaccine
  • Track 17-6Varicella vaccine
  • Track 17-7Diphtheria vaccine
  • Track 17-8AIDS and Retroviral vaccines
  • Track 17-9Tick-Borne Encephalitis vaccines
  • Track 17-10Tuberculosis (BCG Vaccine)
  • Track 17-11Varicella (chickenpox) vaccine
  • Track 17-12Influenza (flu) vaccine
  • Track 17-13Hepatitis A & B vaccine
  • Track 17-14HIV vaccines
  • Track 17-15Genital Herpes vaccine
  • Track 17-16Hepatitis B vaccine
  • Track 17-17Genital Herpes vaccines
With STI surveillance reports, and ad hoc publications related to the distribution of STDs to describe recent trends in the epidemiology of major STIs due to Substantial morbidity, associated mortality, and disproportionate burden, marginalised communities, and those with high risk sexual lifestyles continue to drive their prioritisation in public health and policy arenas. With the newer diagnostic technologies, the verge of a major change in the approach to STI control by molecular amplification, Combination therapy, Stigma impairs cognition, proliferate and mimicking of human genome, immune receptor activation, potential treatment targets, Highly efficacious vaccines, Blocking of HIV DNA to cell nucleus, HIV transcription and latency, Mobile diagnostic tool, Novel antibiotic. When the choice of diagnostic methods are faster and results more accurate, they are bound to improve patient care. The molecular techniques, screening are useful for microorganisms that are difficult to culture. They are being increasingly accepted by clinicians as viable options in their practice. Aseptic technique is the normally applied to prevent the infections caused by different sources of infectious pathogens .
Anti-Retroviral (ARV) Therapies | Vaccination | Stem cell therapy | Nano materials |  Molecular diagnostics | Gene editing  | Mobile Diagnostic Tool | Molecular Therapies
  • Track 18-1Molecular techniques
  • Track 18-2Pharmaceutical design of Drug and mechanism
  • Track 18-3Stem cell therapy
  • Track 18-4Antiviral drugs
  • Track 18-5Anti-Retroviral (ARV) Therapies and Vaccination
  • Track 18-6PER.C6 technology
  • Track 18-7AdVac Technology
  • Track 18-8Nano materials
HIV infection can be diagnosed by serologic tests that detect antibodies against HIV-1 and HIV-2 and by virology tests that can detect HIV antigens or ribonucleic acid (RNA). Drug therapy or treatment for HIV is called Anti-Retroviral Therapy or ART.  By proper medical care, treatment HIV can be controlled. Diagnosis and treatment for STDs should be screened for HIV infection. Women should be screened annually or yearly for cervical cancer precursor lesions by cervical Pap tests. Gonorrhea and chlamydia are bacterial STDs/STIs that can be treated by using potent antibiotics given either orally or by injection. Successful treatment for cancroid cures the infection, resolves the clinical symptoms, and prevents transmission to others.
Anti-Retroviral Therapy | Seronegative | Prevalence | Long term survivor | ELISA | Stigma-CD4 Count | Regimen |  Celibacy | Viral Load |  Adherence  and Activism.
  • Track 19-1Neurosyphilis diagnostics
  • Track 19-2Gemifloxacin
  • Track 19-3Legal status of EPT
  • Track 19-4Bicillin-LA (benzathine penicillin G)
  • Track 19-5Bicillin-LA (benzathine penicillin G)
  • Track 19-6Gonorrhea guidance
  • Track 19-7Expedited Partner Therapy
  • Track 19-8Antibiotic treatment
  • Track 19-9Detection of antibodies
  • Track 19-10Frequent screening
  • Track 19-11Molecular diagnostic
  • Track 19-12Gemifloxacin
Sexually transmitted Infections (STIs) and Sexually Transmitted Diseases (STDs) which rank the most important health concerns for the people especially the young adults worldwide. The development of educational programs, awareness campaigns will play vital role in the fight to control sexually transmitted diseases. The Sexually Transmitted Disease (STD) infection prevention and control program works to reduce the incidence of sexually transmitted diseases. Social media practices to help implement awareness strategies. Awareness and knowledge was generally high for HIV/AIDS (above 90%) and low for HPV (range 5.4%-66%). By providing screening, testing, diagnosis and treatment for infected individuals, the STD program is fighting the war against STD’s for one person at a time. STDs can be simply prevented with three actions (a) Talk openly to partners, patients, and healthcare providers about sexual health and STDs, (b) Ensure everyone knows who should be tested and when, (c) The important role healthcare providers and patients play in making sure STDs are treated correctly.
National promotion | Digital engagement | Campaign website | Adolescents and Youth Awareness | Zero Discrimination | STD testing clinics
  • Track 20-1Lifestyle and home remedies
  • Track 20-2Safe sex
  • Track 20-3Educational programs
  • Track 20-4Avoid intravenous drugs
  • Track 20-5Clinical training
  • Track 20-6Screening Recommendations
  • Track 20-7Advanced treatments
  • Track 20-8Implement strategies